XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 16 - Share Based Awards (Tables)
9 Months Ended
Jan. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Fair Value Assumption, Date of Securitization or Asset-backed Financing Arrangement, Transferor's Continuing Involvement, Servicing Assets or Liabilities [Table Text Block]
Exercise price     1.69 - 2.52  
Stock price on date of grant     1.69 - 2.33  
Volatility     268.51% - 270.18%  
Risk-free interest rate     1.50% - 1.74%  
Expected term (years)     8.258.25  
Dividend yield         
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
Options   Shares   Weighted-Average Exercise Price   Weighted-Average Remaining Contractual Term   Aggregate Intrinsic Value
                                 
Outstanding as of April 30, 2020     1,597,475     $ 1.10                  
Granted     600,000       3.63                  
Exercised                                  
Forfeited or expired                                  
Outstanding as of April 30, 2021     2,197,475     1.79                  
Granted     1,656,000       2.59                  
Exercised     (112,500     0.96                  
Forfeited or expired     (26,000     2.12                  
Outstanding as of January 31, 2022     3,714,975     2.17       8.72     $ 1,010,178  
Exercisable as of January 31, 2022     1,897,142     $ 2.13       8.01     $ 687,111  
Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table Text Block]
        
  

Three months ended

January 31,

 

Nine months ended

January 31,

   2022  2021  2022  2021
General and administrative  $343,549   $336,301   $952,899   $525,559 
Research and development   143,279    179,157    284,511    199,047 
Operations   182,320    170,612    556,928    175,586 
Sales and marketing   112,975    168,125    271,808    168,125 
Total  $782,123   $854,195   $2,066,146   $1,068,317